These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8125830)

  • 21. Enterococci and vancomycin resistance.
    French GL
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S75-83. PubMed ID: 9710674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycopeptide-resistant enterococci isolated from uncooked meat.
    Chadwick PR; Woodford N; Kaczmarski EB; Gray S; Barrell RA; Oppenheim BA
    J Antimicrob Chemother; 1996 Nov; 38(5):908-9. PubMed ID: 8961065
    [No Abstract]   [Full Text] [Related]  

  • 23. [Regulation mechanism of glycopeptide resistance expression].
    Ohno A; Ishii Y; Yamaguchi K
    Nihon Rinsho; 1997 May; 55(5):1206-12. PubMed ID: 9155176
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Glycopeptide antibiotic resistance.
    Pootoolal J; Neu J; Wright GD
    Annu Rev Pharmacol Toxicol; 2002; 42():381-408. PubMed ID: 11807177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occurrence of glycopeptide resistance among Enterococcus faecium isolates from conventional and ecological poultry farms.
    Aarestrup FM
    Microb Drug Resist; 1995; 1(3):255-7. PubMed ID: 9158784
    [No Abstract]   [Full Text] [Related]  

  • 26. Symposium on antimicrobial therapy. IX. The glycopeptide and macrolide antibiotics.
    Greenfield RA
    J Okla State Med Assoc; 1993 Jun; 86(6):269-75. PubMed ID: 8326418
    [No Abstract]   [Full Text] [Related]  

  • 27. [Interactions between bacteria and antimicrobials during the postantibiotic effect phase].
    Pastor A; Cantón E
    Rev Esp Quimioter; 1999 Dec; 12(4):294-9. PubMed ID: 10855007
    [No Abstract]   [Full Text] [Related]  

  • 28. Multiple colonization with highly resistant bacteria: carbapenemase-producing Enterobacteriaceae, carbapenemase-producing Pseudomonas aeruginosa, carbapenemase-producing Acinetobacter baumannii, and glycopeptide-resistant Enterococcus faecium.
    Girlich D; Nordmann P; Lécuyer H; Berche P; Marmorat-Khuong A; Gros I; Cuzon G; Dortet L
    Diagn Microbiol Infect Dis; 2015 Mar; 81(3):217-8. PubMed ID: 25547540
    [No Abstract]   [Full Text] [Related]  

  • 29. Semisynthetic glycopeptides: chemistry, structure-activity relationships and prospects.
    Ciabatti R; Malabarba A
    Farmaco; 1997 May; 52(5):313-21. PubMed ID: 9274002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance of enterococci to aminoglycosides and glycopeptides.
    Leclercq R; Dutka-Malen S; Brisson-Noël A; Molinas C; Derlot E; Arthur M; Duval J; Courvalin P
    Clin Infect Dis; 1992 Sep; 15(3):495-501. PubMed ID: 1520800
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [In vitro activity of a new glycopeptide antibiotic eremomycin in relation to obligate anaerobic Gram-positive bacteria].
    Malkova IV; Borisova OK; Pavlova MV; Zemlianitskaia EP; Sergeeva TI
    Antibiot Khimioter; 1991 Apr; 36(4):17-20. PubMed ID: 1654046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Infectious endocarditis caused by a glycopeptide-resistant enterococus].
    Jouaihia W; Ghozzi R; Kamoun A; Baccar H; Bousnina A; Ben Redjeb S
    Tunis Med; 2000 Nov; 78(11):667-70. PubMed ID: 11155391
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Membrane Disruption and Enhanced Inhibition of Cell-Wall Biosynthesis: A Synergistic Approach to Tackle Vancomycin-Resistant Bacteria.
    Yarlagadda V; Samaddar S; Paramanandham K; Shome BR; Haldar J
    Angew Chem Int Ed Engl; 2015 Nov; 54(46):13644-9. PubMed ID: 26473305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycopeptide resistance in enterococci.
    Méndez-Alvarez S; Pérez-Hernández X; Claverie-Martín F
    Int Microbiol; 2000 Jun; 3(2):71-80. PubMed ID: 11001535
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Negative results of the determination of sensitivity to antibiotics of body microflora in connection with appearance of dysbacteriosis].
    Chernomordik AB
    Lab Delo; 1969; 3():154-7. PubMed ID: 4185179
    [No Abstract]   [Full Text] [Related]  

  • 36. Isolation of glycopeptide resistant Streptococcus gallolyticus strains with vanA, vanB, and both vanA and vanB genotypes from faecal samples of veal calves in The Netherlands.
    Mevius D; Devriese L; Butaye P; Vandamme P; Verschure M; Veldman K
    J Antimicrob Chemother; 1998 Aug; 42(2):275-6. PubMed ID: 9738855
    [No Abstract]   [Full Text] [Related]  

  • 37. [Characteristic of antibiotics and the administrative methods in basic chemotherapy of bacterial infections].
    Totsuka K
    Nihon Naika Gakkai Zasshi; 1990 Dec; 79(12):1627-31. PubMed ID: 2079585
    [No Abstract]   [Full Text] [Related]  

  • 38. Mechanism of action of oritavancin and related glycopeptide antibiotics.
    Allen NE; Nicas TI
    FEMS Microbiol Rev; 2003 Jan; 26(5):511-32. PubMed ID: 12586393
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [New quinolones].
    Matsumoto F; Morita M; Sato Y
    Nihon Rinsho; 1990 Oct; 48(10):2205-11. PubMed ID: 2177796
    [No Abstract]   [Full Text] [Related]  

  • 40. [Chemical modification of glycopeptide antibiotics].
    Pavlov AIu; Preobrazhenskaia MN
    Bioorg Khim; 1998 Sep; 24(9):644-62. PubMed ID: 9813730
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.